Key result
2023 ESC guidelines consolidate STEMI and NSTEMI management into one document with 37 new recommendations.
Why the study?
The 2023 ESC guidelines merged STE-ACS and NSTE-ACS management into a single document, prompting a need to compare these with ACC/AHA guidelines and highlight new recommendations.
This review provides a North American perspective on the 2023 ESC ACS guidelines, highlighting key differences from ACC/AHA guidelines in areas such as antithrombotic therapy and post-cardiac arrest temperature control.
North American clinicians should note ESC-ACC/AHA divergences in antithrombotics and temperature control; leaves open unified guideline development.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ortega‐Paz et al. (2023) conducted a review in Acute Coronary Syndromes. 2023 ESC Guidelines vs. ACC/AHA Guidelines was evaluated. The 2023 ESC guidelines for acute coronary syndromes introduce 37 new and 9 revised recommendations, consolidating ST-elevation and non-ST-elevation ACS management into a single document.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: